4 recruiting, 3 completed, 1 terminated, 1 unknown. 4 Phase 2, 2 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Unknown 1 |
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 2 |
Follow Thalassemia, Beta: new trials by email Literature Review of Thalassemia, Beta trials Research Report on Thalassemia, Beta
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Follow-up Study of BRL-101 for TDT Assessments - Thalassemia, Beta | Recruiting | Bioray Laboratories | 45 | 2024-12-08 | 2026-07-21 | |
| Impact of Virtual Reality on Pain and Anxiety During Intravenous Cannulation Procedures Among Thalassemia Patients in UAE. Headset-based Virtual Reality Simulation - Thalassemia, Beta, Thalassemia | Not applicable | Completed | Mohammed Bin Rashid University of Medicine and Health Sciences | 115 | 2024-05-24 | 2025-08-01 |
| Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells VGB-Ex01 - Thalassemia, Beta, Thalassemia Major | Not applicable | Terminated | Institute of Hematology & Blood Diseases Hospital, China | 1 | 2023-08-31 | 2026-11-04 |
| A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) Fludarabine, Cyclophosphamide, Tacrolimus - Sickle Cell Disease, Thalassemia, Beta | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 24 | 2023-02-09 | 2026-06-03 |
| Long-term Follow-up Study of BHC001 for TDT Assessments - Thalassemia, Beta | Recruiting | Bioray Laboratories | 6 | 2022-12-14 | 2024-03-18 | |
| Study of the Role of Genetic Modifiers in Hemoglobinopathies GWAS - Sickle Cell Disease, Thalassemia, Beta | Recruiting | Cyprus Institute of Neurology and Genetics | 30000 | 2022-10-01 | 2024-03-20 | |
| Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients Hydroxyurea and Thalidomide - Thalassemia, Beta | Phase 2 / Phase 3 | Completed | Children's Hospital Karachi | 603 | 2020-07-07 | 2023-12-01 |
| Clinical Experience of Thalidomide in Thalassemic Patients hydroxyurea and thalidomide - Thalassemia, Beta | Phase 2 / Phase 3 | Completed | Children's Hospital Karachi | 135 | 2020-01-01 | 2021-11-24 |
| The Efficacy and Safety of HYDROXYUREA in Management of Beta Thalassemia Patients in Karachi Pakistan Hydroxyurea - Thalassemia, Beta | Phase 2 | Unknown | Dr.Saqib Hussain Ansari | 100 | 2017-08-21 | 2017-09-20 |
beta-Thalassemia (9) · Thalassemia (3) · Anemia, Sickle Cell (2) · Anxiety Disorders (1) · Hematologic Diseases (1) · Hemoglobinopathies (1) · Pain (1) · alpha-Thalassemia (1)
Anemia (9) · Anemia, Hemolytic (9) · Anemia, Hemolytic, Congenital (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Genetic Diseases, Inborn (9) · Hemic and Lymphatic Diseases (9) · Hematologic Diseases (8) · Hemoglobinopathies (8) · Thalassemia (6) · Mental Disorders (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Hydroxyurea (3) · Thalidomide (2) · Bortezomib (1) · Cyclophosphamide (1) · Dexamethasone (1) · Mycophenolic Acid (1) · Rituximab (1) · Tacrolimus (1) · fludarabine (1) · thymoglobulin (1)
Bioray Laboratories (2) · Children's Hospital Karachi (2) · Cyprus Institute of Neurology and Genetics (1) · Dr.Saqib Hussain Ansari (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Memorial Sloan Kettering Cancer Center (1) · Mohammed Bin Rashid University of Medicine and Health Sciences (1)
Pakistan (4) · China (3) · United States (2) · Angola (1) · Argentina (1) · Belgium (1) · Brunei (1) · Cyprus (1) · Democratic Republic of the Congo (1) · Denmark (1) · Greece (1) · Israel (1) · Italy (1) · Malaysia (1) · Nigeria (1)
Jun Shi, PhD (1) · Maria Cancio, MD (1) · Petros Kountouris, PhD (1) · Rongmei Liang, PhD (1) · Saqib H Ansari, MBBS, DCH, DPGN, Mphil, PhD (1) · Saqib H Ansari, Phd (1) · Xiaochen Wang, PhD (1)